MedPath

Eposis

Brand Name: Eposis

Generic Name: Recombinant Human Erythropoietin Alfa

Active
Registration Number

BR-868

Dosage Form

Solution For Injection (I.V./S.C.)

Issuance Date

April 1, 2022

Expiry Date

May 17, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10,000 I.U./mL
Packaging1mL pre-filled Type I glass syringe with needle in individually sealed plastic tray

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Hematopoietic Growth Factor
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Recombinant Human Erythropoietin AlfaActive
Monograph: Erythropoietin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform